Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.22
Delayed Data
As of Feb 16
 -0.01 / -4.35%
Today’s Change
0.03
Today|||52-Week Range
0.35
-18.52%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.23
Today’s open0.22
Day’s range0.22 - 0.23
Volume12,842
Average volume (3 months)78,431
Market cap$9.7M
Data as of 1:13pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-106.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-52.01%
P/E ratio--
Price/Sales1.93
Price/Book0.94

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$8.4M
Annual profit (last year)-$1.1M
Net profit margin-13.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Chief Financial &
Accounting Officer, VP-Finance
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts